Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification

NCT02084576 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cystoid Macular Edema
Cataract

Interventions

DRUG: Nepafenac
DRUG: Ketorolac

Sponsor

Hospital Oftalmologico de Brasilia